| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733506 | Critical Reviews in Oncology/Hematology | 2018 | 8 Pages |
Abstract
PFS is strongly correlated with OS in trials of advanced/metastatic urothelial cancer assessing the treatment benefit of new drugs And PFS warrants further exploration as a surrogate endpoint in clinical trial datasets.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Fei Liang, Sheng Zhang, Qing Wang, Wenfeng Li,